Acute Ischemic Stroke Clinical Trial
Official title:
Effects of Biofeedback Combined With Abdominal Breathing on Physiological and Psychological Aspects in Patients With Acute Cerebral Infarction
The major aim of this study is to investigate the effects of biofeedback assisted abdominal breathing training on improving the psychological and physiological distress in patients with ACI. In this randomized, controlled, single-blind trial, AIS patients were randomly assigned into experimental and control groups. The experimental group received four HRVBF training sessions. The control group received routine care. Repeated measures of HRV, Mini-Mental Status Examination (MMSE), Hospital Anxiety and Depression Scales (HADS), and Barthel Index for ADLs were collected prior to, and at one, and three months post-intervention.
Study protocol Participants who provided signed consent were randomly assigned to HRVBF
intervention or control group. They underwent baseline measurements of demographics,
psychological distress, cognitive impairment, ADL capabilities, and autonomic function.
Random numbers from the Bernoulli distribution were calculated using the Excel BINOMDIST
function, and concealed in an opaque envelope, until participants' baseline measurements were
completed.
The HRVBF group received four, one-on-one bedside biofeedback training sessions (20-minutes a
day for 4 days), and practiced on their own (10-minutes twice a day) using a FDA-regulated,
hand-held mobile biofeedback device (StressEraser, Helico Inc., New York, NY, USA).26 The
control group received usual care. Afterwards, all participants were telephoned bi-weekly and
encouraged to practice slow breathing (HRVBF group) or to perform self-care (control group)
for three months. psychological distress, cognitive impairment, ADL capabilities, and
autonomic function (represented by HRV) were re-assessed at one, and 3-months after the
intervention, by an independent investigator blinded to group assignment.
HRVBF intervention protocol The HRVBF protocol was modified from Lehrer's HRV biofeedback
manual.20 A noninvasive visual biofeedback system (NeXus-10 with BioTrace+, Mind Media B.V.,
Netherlands) and a laptop computer were used for the intervention. Participants in the HRVBF
group received four, one-on-one bedside training sessions (20-minutes a day for 4 days). The
first session (Day 1) was focused on teaching patients to breath slowly (6-8
breaths-per-minute) and to extend their expiratory phase using pursed-lip breathing. Also,
respiration sensors for tracking breathing pace were introduced. The second session (day 2)
was focused on teaching patients diaphragmatic breathing in conjunction with pursed-lip
breathing, and to use respiratory sensors to pace breathing (6 breaths a minute). The third
and fourth sessions (days 3 and 4) were focused on reviewing diaphragmatic breathing,
pursed-lip breathing, and teaching patients to breathe in-phase with their heart rate
changes. Additionally, participants were encouraged to practice slow diaphragmatic and
pursed-lip breathing, on their own, with the aid of the hand-held biofeedback device, for 10
minutes, twice-a-day, during the 4-day training period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06113848 -
Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy
|
Phase 3 | |
Completed |
NCT04069546 -
The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency
|
N/A | |
Active, not recruiting |
NCT05700097 -
Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
|
Phase 2 | |
Recruiting |
NCT06058130 -
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
|
N/A | |
Recruiting |
NCT04415164 -
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
|
Phase 4 | |
Recruiting |
NCT05363397 -
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
|
Phase 2 | |
Completed |
NCT05429658 -
Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System
|
N/A | |
Recruiting |
NCT05390580 -
Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct
|
N/A | |
Enrolling by invitation |
NCT05515393 -
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
|
Phase 2 | |
Active, not recruiting |
NCT05070260 -
ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo
|
Phase 2/Phase 3 | |
Terminated |
NCT05547412 -
Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke
|
||
Completed |
NCT03366818 -
New Stent Retriever, VERSI System for AIS
|
N/A | |
Not yet recruiting |
NCT06437431 -
Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06040476 -
Human Umbilical Cord Blood Infusion in Patients With Acute Ischemic Stroke (AIS)
|
Phase 2 | |
Not yet recruiting |
NCT05293080 -
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
|
Phase 3 | |
Completed |
NCT02223273 -
Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke)
|
N/A | |
Completed |
NCT02586233 -
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
|
Phase 1/Phase 2 | |
Terminated |
NCT01694381 -
Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor
|
Early Phase 1 | |
Not yet recruiting |
NCT01594190 -
Physical Activity Immediately After Acute Cerebral Ischemia
|
N/A | |
Completed |
NCT01120301 -
Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
|
Phase 3 |